As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
HHS invests nearly $600 million in Moderna’s bird flu vaccine development
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
GlobalData on MSN1d
Valneva announces positive outcomes from chikungunya vaccine trial
Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus ...
As bird flu concerns grow, scientists race to develop new vaccines
As fears grow of a possible bird flu pandemic in humans, the federal government is pouring more money into the development of ...
GlobalData on MSN6d
Evaxion concludes subject dosing in Phase II trial of melanoma vaccine
Evaxion Biotech has completed subject dosing in the Phase II trial of EVX-01, for the treatment of advanced melanoma.
FierceBiotech1d
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
Healio1d
Trial of vaccine for triple-negative breast cancer yields ‘encouraging’ results
Nearly 75% of women treated with a novel vaccine designed to prevent triple-negative breast cancer achieved an immune ...
GlobalData on MSN1d
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
Whilst vaccines exist for animals, none are commercially available for human use for the mosquito-borne virus.
Taiwan News12h
Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision
Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...
Deccan Chronicle2d
FACT CHECK: Does the COVID-19 vaccine contain AIDS causing viruses?
CLAIM: HIV is part of the composition of COVID-19 vaccinesFACT: False. An experimental vaccine developed by Professor Keith ...
Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01
Trial remains on track for completion and data readout in the second half of 2025COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S ...
Nasdaq13d
IO Biotech Completes Enrollment Ahead of Schedule in Phase 2 Clinical Trial for Novel Cancer Vaccine IO102-IO103
IO Biotech has successfully completed enrollment ahead of schedule for its Phase 2 clinical trial (IOB-032/PN-E40) studying the immune-modulatory cancer vaccine IO102-IO103 in combination with ...